RVII Short Volume
Robinhood Ventures Fund II (RVII) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $10.9M, listed on NYSE, carrying a beta of 0.00 to the broader market. Robinhood Ventures Fund II engages in providing retail investors with exposure to private, early-stage and growth-stage companies that have traditionally been accessible primarily to venture capital firms, institutions, and accredited investors. public since 2026-08-13.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-28
- Short Volume
- 79.6K
- Total Volume
- 163.3K
- Short %
- 48.74%
- 30-Day Avg Short %
- 45.96%
Showing 12 days of FINRA short volume data for Robinhood Ventures Fund II.
Learn how short volume is reported and how to read the data →
Frequently asked RVII short volume questions
- What is the daily RVII short volume?
- As of Aug 28, 2026, Robinhood Ventures Fund II (RVII) short volume is 79.6K shares against 163.3K total reported volume, or 48.74% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is RVII short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does RVII short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.